tiprankstipranks
Bionano Genomics (BNGO)
NASDAQ:BNGO
US Market
BNGO
BioNano Genomics
RESEARCH TOOLSreports

BioNano Genomics (BNGO) Financial Statements

9,205 Followers

BioNano Genomics Financial Overview

BioNano Genomics's market cap is currently $12.87M. The company's EPS TTM is $-2.32; its P/E ratio is -0.32; BioNano Genomics is scheduled to report earnings on March 23, 2026, and the estimated EPS forecast is $-0.88. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Mar 25Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 28.51M$ 30.78M$ 36.12M$ 27.80M$ 17.98M
Gross Profit$ 6.26M$ 380.00K$ 9.57M$ 5.95M$ 3.87M
Operating Income$ -33.34M$ -103.98M$ -215.25M$ -131.70M$ -77.10M
EBITDA$ -23.61M$ -97.47M$ -213.60M$ -120.31M$ -73.86M
Net Income$ -26.39M$ -112.02M$ -232.49M$ -132.60M$ -72.44M
Balance Sheet
Cash & Short-Term Investments$ 13.26M$ 9.47M$ 66.77M$ 113.19M$ 250.61M
Total Assets$ 73.58M$ 76.67M$ 214.40M$ 307.50M$ 377.10M
Total Debt$ 6.92M$ 27.30M$ 79.41M$ 11.67M$ 10.70M
Net Debt$ 3.92M$ 18.12M$ 61.47M$ 6.58M$ -13.88M
Total Liabilities$ 29.16M$ 41.30M$ 118.25M$ 58.10M$ 39.98M
Stockholders' Equity$ 44.42M$ 35.38M$ 96.16M$ 249.40M$ 337.12M
Cash Flow
Free Cash Flow$ -16.34M$ -69.03M$ -126.87M$ -128.12M$ -73.39M
Operating Cash Flow$ -16.34M$ -68.92M$ -125.18M$ -124.82M$ -71.93M
Investing Cash Flow$ -12.75M$ 73.84M$ 24.16M$ 82.77M$ -278.06M
Financing Cash Flow$ 24.04M$ -13.69M$ 113.81M$ 23.01M$ 336.11M
Currency in USD

BioNano Genomics Earnings and Revenue History

Income Statement >

BioNano Genomics Debt to Assets

Balance Sheet >

BioNano Genomics Cash Flow

Cash Flow >

BioNano Genomics Forecast EPS vs Actual EPS

Earnings >